Thanks for the info. I trade with comsec. I'll look up their rates but if that's all that's involved it seems pretty simple and the cost is ok.Look like I might go with the 'stick it in the bottom drawer' approach
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
